Cary Street Partners Investment Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Buy
1,851
+663
+56% +$58K 0.03% 408
2026
Q1
$101K Buy
1,188
+418
+54% +$37.3K 0.03% 451
2025
Q4
$60.8K Sell
770
-176
-19% -$13.8K 0.02% 490
2025
Q3
$75.6K Buy
946
+35
+4% +$2.99K 0.03% 395
2025
Q2
$82.8K Buy
911
+137
+18% +$12.5K 0.04% 346
2025
Q1
$72.5K Buy
774
+230
+42% +$20.6K 0.04% 333
2024
Q4
$49.5K Sell
544
-18,521
-97% -$1.77M 0.03% 319
2024
Q3
$1.98M Sell
19,065
-215
-1% -$21.9K 0.07% 271
2024
Q2
$1.87M Buy
19,280
+677
+4% +$62.5K 0.08% 260
2024
Q1
$1.68M Buy
18,603
+13
+0.1% +$1.1K 0.07% 271
2023
Q4
$1.48M Buy
18,590
+444
+2% +$33.4K 0.07% 267
2023
Q3
$1.29M Buy
18,146
+10,964
+153% +$820K 0.07% 271
2023
Q2
$553K Sell
7,182
-50
-0.7% -$3.87K 0.04% 341
2023
Q1
$543K Sell
7,232
-742
-9% -$55.2K 0.04% 324
2022
Q4
$628K Sell
7,974
-134
-2% -$10K 0.05% 300
2022
Q3
$570K Sell
8,108
-220
-3% -$17.3K 0.05% 293
2022
Q2
$667K Buy
8,328
+2,674
+47% +$209K 0.06% 265
2022
Q1
$429K Buy
+5,654
New +$448K 0.12% 167
2021
Q3
Sell
-962
Closed -$78K 260
2021
Q2
$78K Hold
962
0.03% 273
2021
Q1
$76K Sell
962
-6,245
-87% -$489K 0.03% 252
2020
Q4
$616K Sell
7,207
-26,905
-79% -$2.22M 0.12% 159
2020
Q3
$2.63M Buy
+34,112
New +$2.6M 0.56% 55

Other funds holding CL

Cary Street Partners Investment Advisory's CL Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Colgate-Palmolive (CL) stake by 56% in Q2 2026, buying an estimated $58K and bringing the position to 1,851 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #408.

Cary Street Partners Investment Advisory first reported a position in CL in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.63M in Q3 2020. 975 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cary Street Partners Investment Advisory held 1,851 shares of Colgate-Palmolive worth $170K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 663 Colgate-Palmolive shares in Q2 2026, an estimated $58K.
  • Colgate-Palmolive made up 0.03% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #408 holding.
  • Cary Street Partners Investment Advisory first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 22 quarters since.
  • Cary Street Partners Investment Advisory's Colgate-Palmolive position peaked at $2.63M in Q3 2020.
  • 975 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.